20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Identification methods for ergothioneine transporter modulators and therapeutic uses thereof
#4502COMPOSITION AND METHOD FOR CLUSTERIN-MEDIATED STEM CELL THERAPY FOR TREATMENT OF ATHEROSCLEROSIS AND HEART FAILURE
#4503Componds and methods for pormoting angiogenesis
#4504Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#4505R-SPONDIN COMPOSITIONS AND METHODS OF USE THEREOF
#4506Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
#4507REMEDY FOR NERVE CELL REGENERATION
#4508Antibodies against a peptide epitope of apolipoprotein B
#4509Antibodies against a peptide epitope of apoliprotein B
#4510Mutant adeno-associated virus virions and methods of use thereof
#4511Compositions and methods for treatment of microbial disorders
#4512Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
#4513Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
#4514Intestinal epithelial glucose sensor
#4515USE OF COMPOUNDS THAT INTERFERE WITH THE HEDGEHOG SIGNALING PATHWAY FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTING, INHIBITING, AND/OR REVERSING OCULAR DISEASES RELATED WITH OCULAR NEOVASCULARIZATION
#4516FKBP-L and uses thereof
#4517CXCR4 ANTAGONIST TREATMENT OF HEMATOPOIETIC CELLS
#4518Casein derived peptides and uses thereof
#4519RECOMBINANT VWF FORMULATIONS
#4520Inhibition of Interaction of PSD93 and PSD95 with nNOS and NMDA Receptors
#4521Methods and reagents for vaccination which generate A CD8 T cell immune response
#4522Prevention and treatment of amyloidogenic disease
#4523Methods for manipulating phagocytosis mediated by CD47
#4524Polypeptide targeting to mitochondria
#4525Method for the treatment of valvular disease
#4526Truncated Activin Type II Receptor and Methods of Use
#4527USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID, SPHINGOLIPID AND CHOLESTEROL.
#4528Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
#4529Methods of suppressing microglial activation and systemic inflammatory responses
#4530Approach to the treatment of compartment syndrome
#4531METHODS AND PREPARATIONS FOR CURING CRITICALLY ILL PATIENTS
#4532Method for treating amyloid disease
#4533Prelamin A pre peptide as a universal stem cell differentiation signal
#4534Inflammation-inhibitory serum factors and uses thereof
#4535F11 receptor (F11R) antagonists as therapeutic agents
#4536HSP THERAPY IN CONJUNCTION WITH A LOW ANTIGENICITY DIET
#4537Anti-angiogenic agents and methods of their use
#4538Milk Derived Composition and Use to Enhance Muscle Mass or Muscle Strength
#4539METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES
#4540Treatment of bacterial infections
#4541Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
#4542DENTAL PRODUCTS COMPRISING BONE GROWTH ENHANCING PEPTIDE
#4543Alzheimer's disease treatment method
#4544Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases
#4545Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
#4546GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN
#4547Approach to treat intraocular hypertension
#4548METHODS OF INHIBITING ANGIOGENESIS WITH FRAGMENTS AND HOMOLOGS OF TROPONIN SUBUNIT I
#4549Methods of NAD-dependent deacetylation of a lysine residue in a protein
#4550Modified defensins and their use
#4551Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#4552Use of immunesuppressant receptor
#4553Method for Inhibition of Phospholamban Activity for the Treatment of Cardiac Disease and Heart Failure
#4554Oxidant resistant apolipoprotein A-1 and mimetic peptides
#4555Modulation of lipid rafts
#4556Vasostatin as marrow protectant
#4557Use of survivin to treat kidney failure
#4558Treatment of neurological deficits in the striatum or substanta nigra pars compacta
#4559Pharmaceutical composition for treating immune diseases
#4560Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease
#4561PLATELET GLYCOPROTEIN IB ALPHA FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#4562Nutritional composition for controlling blood sugar level
#4563Use of ferritin to treat iron deficiency disorders
#4564B7-H4 RECEPTOR AGONIST COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND AUTO-IMMUNE DISEASES
#4565METABOLIC REGULATORS AND USES THEREOF
#4566DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE
#4567Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1
#4568ENGINEERED INTERVERTEBRAL DISC TISSUE
#4569METHODS OF TREATING AND DIAGNOSING LAMINOPATHY
#4570NOVEL USE
#4571Food Product for Enteral or Oral Nutrition
#4572Protein formulation
#4573Mitochondrial localization of MUC1
#4574Chronic lymphocytic leukemia prognosis and treatment
#4575Ubiquitin-like protein isg15 for hiv inhibition
#4576Agents for reducing injury to mammalian cells
#4577Treatment of subarachnoid hemorrhage with Apo E analogs
#4578ICA512 COUPLES INSULIN SECRETION AND GENE EXPRESSION IN BETA-CELLS
#4579Screening method for compounds that promote differentiation of inner ear progenitor cells
#4580Compositions and methods for regulating apoptosis
#4581Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
#4582TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASES
#4583Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesity
#4584Peptide epitopes of apolipoprotein B
#4585PEPTIDE EPITOPES OF APOLIPOPROTEIN B
#4586RTEF-1 variants and the use thereof for inhibition of angiogenesis
#4587Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#4588Granulysin peptides and methods of use thereof
#4589Methods and compositions related to PLUNC surfactant polypeptides
#4590Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity
#4591Pharmaceutical composition containing decoy and method of using the same
#4592Methods for stabilizing corneal tissue
#4593CYTOKINE RECEPTOR MODULATORS, METHOD OF IDENTIFYING SAME, AND METHOD OF MODULATING CYTOKINE RECEPTORS ACTIVITY WITH SAME
#4594Methods for attenuating virus strains for diagnostic and therapeutic uses
#4595Technology for the Preparation of Microparticles
#4596METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA MODULATION OF MEGALIN ACTIVITY
#4597Agents capable of downregulating an MSF-A dependent HIF-1α and use thereof in cancer treatment
#4598Laminins, derivatives, and compositions including same and methods for their therapeutic use
#4599NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#4600Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
#4601Agent for inducing apoptosis comprising MSX1 or a gene encoding the same as an active ingredient
#4602Use of Light Sensitive Genes
#4603Use of the cathelicidin LL-37 and derivatives therof for wound healing
#4604Pharmaceutical composition useful for the treatment of invasive pulmonary aspergillosis
#4605AGENTS THAT REDUCE APOE-INDUCED IMPAIRMENT OF MITOCHONDRIA AND METHODS OF USE THEREOF
#4606Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells
#4607NON-PANCREATIC PROTEASES FOR CONTROLLING PLASMA CHOLECYSTOKININ (CCK) CONCENTRATION AND FOR TREATING PAIN
#4608HIV Transcription Repressor Complex and Compositions and Methods Based Thereon
#4609Method for screening substance having proangiogenic effect
#4610Therapeutic angiogenesis for treatment of the spine
#4611Bone/joint disease sensitivity gene and use thereof
#4612Inhibition of angiogenesis by neutrophil alpha-defensins
#4613ANTITUMOR EFFECT OF MUTANT BIK
#4614Method for ameliorating dyskinesia
#4615MOLECULAR INTERACTIONS IN CELLS
#4616Antiviral peptides
#4617Antimicrobial peptides with heparin binding activity
#4618Methods for addressing ocular diseases through interference with the wnt signaling pathway
#4619Methods and compositions useful in the treatment of mucositis
#4620Vldlr-/- mouse models and related methods
#4621Treatment of disease by inducing cell apoptosis
#4622Cell-permeable peptide inhibitors of the JNK signal transduction pathway
#4623COMPOSITIONS AND METHODS FOR TREATING DIABETIC EYE DISEASE
#4624Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
#4625Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
#4626GENE TRANSFER FOR REGULATING SMOOTH MUSCLE TONE
#4627COMPOSITIONS AND METHODS FOR CANCER TREATMENT USING TARGETED SINGLE-WALLED CARBON NANOTUBES
#4628INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES
#4629Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same
#4630Protein formulation
#4631Methods and compositions for regulating T cell subsets by modulating transcription factor activity
#4632Hydrophobically-modified protein compositions and methods
#4633Peptides which bind to G protein-coupled receptors
#4634Use of heat-shock protein 27 for cardiovascular disease prevention and treatment
#4635Combinatorial improvement of bifunctional drug properties
#4636Peptide inhibitors of cyclin-dependent kinase activity and uses thereof
#4637High temperature stable peptide formulation
#4638METHOD FOR INDUCING DEPOSITION AND MATURATION OF BONE COMPRISING A CO-THERAPEUTIC REGIMEN OF LMP-1 AND BMP-2
#4639Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith
#4640Pharmaceutical compositions for treating or preventing bone conditions
#4641RECOMBINANT HUMAN ALPHA-FETOPROTEIN AS AN IMMUNOSUPPRESSIVE AGENT
#4642Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#4643Cytokine induction of selectin ligands on cells
#4644Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
#4645Therapy for primary and metastatic cancers
#4646Treatment of cellular proliferative disorders
#4647ANTI-HIV AGENT
#4648KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE
#4649Insulin-Like Growth Factor Binding Protein-4 Compounds and Methods for Inhibiting Angiogenesis and Tumor Growth in Mammalian Cells
#4650COMPOSITIONS AND METHODS FOR THERAPEUTIC USE
#4651TISSUE FACTOR COMPOSITIONS AND METHODS
#4652METHODS FOR INCREASING CELL OR TISSUE REGENERATION IN A VERTEBRATE SUBJECT
#4653Nell-1 enhanced bone mineralization
#4654Chaperonin 10-induced immunomodulation
#4655Oligopeptide treatment of ischemia reperfusion injury
#4656INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES
#4657APO E analogs and methods for their use
#4658MODULATORS OF PARAPTOSIS AND RELATED METHODS
#4659CD34 stem cell-related methods and compositions
#4660Composition And Method For Brain Tumor Therapy
#4661Methods for identifying agents for treating cardiovascular disease using inhibition of myeloperoxidase binding
#4662METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS & IMPAIRED LUNG FUNCTION & TO ENHANCE LYMPHOCYTE PRODUCTION
#4663Modulation of synaptogenesis
#4664Uteroglobin in the treatment of IGA mediated nephropathy
#4665HIFαprolyl hydroxylation assay
#4666Chlamydia Antigens and Uses Thereof
#4667Treatment of depression, psychosis, and anxiety
#4668NOD1 as an Anti-Tumor Agent
#4669Identification of Agonistic Autoantibodies Associated with Humoral Kidney Rejection
#4670Treatment of EGFR-dependent tumors by ABIN (a20 -binding inhibitor of NF kappab)
#4671Methods for detecting and treating interstitial cystitis
#4672Attractin/mahogany-like polypeptides
#4673IGF-1 RECEPTOR INTERACTING PROTEINS
#4674Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same
#4675APOLIPOPROTEIN E STABLE FOLDING INTERMEDIATE AND METHODS OF USE THEREOF
#4676Inhibition of pancretic cancer cell growth
#4677Article of manufacture
#4678Use of Surfactant Preparations for the Treatment of Surgical Adhesions
#4679PHARMACEUTICAL COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT OR ERP57 TRANSLOCATION
#4680Antibodies to Stra6 polypeptides
#4681Compositions and Methods of Treating Tumors
#4682Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis
#4683Compositions and methods for modulating PGC-1α to treat huntington's disease
#4684SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION
#4685METHOD, APPARATUS, AND COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER
#4686Ammonium/Ammonia Transporter
#4687METHOD FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION
#4688Method for modulating appetite
#4689PHARMACEUTICAL COMPOUND FOR BLOCKING THE CRT OR ERP57 TRANSLOCATION
#4690COMPOSITIONS AND METHODS INVOLVING GENE THERAPY AND PROTEASOME MODULATION
#4691Blood group antigen fusion polypeptides and methods of use thereof
#4692Compositions of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
#4693Peptide epitopes of apolipoprotein B
#4694Peptides for the treatment of herpes virus infections
#4695Process for the determination of inflammatory processes and pharmaceutical compositions for the treatment thereof
#4696Anti-Inflammatory Peptides and Methods of Use Thereof
#4697Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof
#4698AMPLIFICATION OF HUMAN MDM2 GENE IN HUMAN TUMORS
#4699Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer
#4700Gastrointestinal proliferative factor and uses thereof
#4701Stra6 polypeptides
#4702METHODS AND COMPOSITIONS FOR NERVE REGENERATION
#4703Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#4704Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours
#4705Pharmaceutical Formulations, Methods, and Dosing Regimens for the Treatment and Prevention of Acute Coronary Syndromes
#4706Pigment epithelium-derived factor as a therapeutic agent for vascular leakage
#4707ENRICHED HAPTOGLOBIN POLYMERS FOR THE TREATMENT OF DISEASE
#4708Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog
#4709Methods of Identifying Agents Having Antiangiogenic Activity
#4710Compositions and Methods for Viscosupplementation
#4711Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate CD4+ and CD8+ T cell immunity
#4712Conjugate Comprising P21 Protein for the Treatment of Cancer
#4713TREATMENT OF VASCULAR ABNORMALITIES USING NANOPARTICLES
#4714Methods and Agents for Modulating Cellular Activity
#4715Modulation of MUC1 activity
#4716METHOD FOR SELECTIVELY TRANSDUCING PATHOLOGIC MAMMALIAN CELLS USING A TUMOR SUPPRESSOR GENE
#4717COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS
#4718Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases
#4719Compositions and methods for treating vascular permeability
#4720RLIP76 liposomes for protection against irradiation
#4721Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical Compositions
#4722LEUCINE RICH COMPOSITION
#4723Methods and compositions for modulating vascular integrity
#4724Biglycan and related therapeutics and methods of use
#4725Peptide epitopes of apolipoprotein B
#4726Method for Treating Neurological Disorders
#4727Compositions and methods for modulating the immune system
#4728Methods of Inhibiting Proinflammatory Cytokine Expression Using Ghrelin
#4729Method of treating dyslipidemic disorder
#4730Peptide epitopes of apolipoprotein B
#4731Use of stem cells to generate inner ear cells
#4732STEROID CONJUGATES, PREPARATION THEREOF AND THE USE THEREOF
#4733Compositions and methods for regulating cardiac performance
#4734Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
#4735USE OF GELSOLIN TO TREAT INFECTIONS
#4736Detection of biomarkers for neuropsychiatric disorders
#4737Peptide inhibitors of IASPP
#4738Preventives/Remedies for Cancer
#4739Methods and compositions to regulate iron metabolism
#4740Compositions and methods relating to prevention of chemotherapy-induced alopecia
#4741Method of treating atherosclerosis
#4742Method of Treating Acute Renal Failure with Thrombomobulin Variant
#4743Treatment of Neurological Deficits in the Striatum or Substanta Nigra Pars Compacta
#4744LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM
#4745Method Of Inducing Apoptosis In Lymphoid Cells
#4746THERAPEUTIC AGENT FOR CANCER, INFLAMMATION, AND AUTO-IMMUNE DISEASE CONTAINING INHIBITOR OF ZINC FINGER PROTEIN 91
#4747IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
#4748Composition for the therapy of diabetes mellitus and adiposity
#4749Conjugate of insulin and vitamin B12 for oral delivery
#4750Wound healing agent and composition
#4751COMPOSITIONS AND METHODS FOR PROTECTING ORGANS, TISSUE AND CELLS FROM IMMUNE SYSTEM-MEDIATED DAMAGE
#4752IMMUNIZATION AGAINST AMYLOID PLAQUES USING DISPLAY TECHNOLOGY
#4753Methods for reducing viral load in HIV-1-infected patients
#4754MUC1-IκB kinase complexes and their activities
#4755Bone morphogenic protein binding peptide
#4756Method for Preventing and Treating Diabetes Using Neurturin
#4757Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#4758Compounds and methods for detection of carcinomas and their precursor lesions
#4759Use of DMBT1 for capturing sulphate and phosphate group exposing agents
#4760Use of sulglicotide for the treatment of mucositis
#4761TAT-BH3 methods for treating arthritis
#4762Methods and compositions of IG20 and DENN-SV splice variants
#4763Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases
#4764Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
#4765Compositions and methods for cell dedifferentiation and tissue regeneration
#4766Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#4767PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#4768Prevention and treatment of amyloidogenic disease
#4769Apoptosis-inducing agent and method for inducing apoptosis
#4770Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain
#4771COMPOSITION AND METHOD FOR CANCER TREATMENT USING TARGETED SINGLE-WALLED CARBON NANOTUBES
#4772Expanding the eukaryotic genetic code
#4773Use of repeat sequence protein polymers in personal care compositions
#4774Methods of treatment involving p21/CIP1
#4775Methods and compositions for treating disorders involving excitotoxicity
#4776Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
#4777Composition and Methods for the Treatment of Duchene Muscular Dystrophy
#4778Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis
#4779Compositions for Inhibiting Cell Growth and Inducing Apoptosis in Cancer Cells and Methods of Use Thereof
#4780Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
#4781Novel Cancer Indications of Mannan-Binding Lectin (Mbl) in the Treatment of Immunocompromised Individuals
#4782Treatment of endothelial dysfunction in diabetic patients
#4783CHEMOREPULSION OF CELLS
#4784Systemic viral/ligand gene delivery system and gene therapy
#4785Methods and compositions for treatment of myotonia
#4786Use of CCN5 for treatment of smooth muscle proliferation disorders
#4787Methods and compositions for diagnosis and therapy of cancer based on hyper-mutated tumor genes
#4788Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands
#4789COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
#4790Compositions and methods for modulating PGC-1β to treat lipid-related diseases and disorders
#4791Recombinant Newcastle Disease Virus
#4792Use of AIM3 acting as a tumor suppressor
#4793Diagnostic markers of human female infertility
#4794Oral Composition For Moisturizing Skin
#4795Role for SRY in Parkinson's disease
#4796Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
#4797Effect of LMP-1 overexpression on large and small proteoglycans of the disc
#4798Polynucleotides encoding signal peptide-containing molecules
#4799Treatment for spinal muscular atrophy
#4800Apelin and uses thereof